Therefore, we will subsequently validate the findings in a PD mouse model and collect time-series physical examination cohort population data to verify the difference between MAPKAPK2 expression in PD patients and HCs, and we will also perform experiments involving gene editing to determine whether the proposed molecular mechanisms is valid. Here, MAPKAPK2 is linked to Parkinson disease.